Hua Huang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Hua Huang has a total of 48 co-authors. Here are the top co-authors by number of shared publications:
Lin Ji
Reproductive Hospital of Guangxi Zhuang Autonomous Region, No. 3, Longyuan Road, Qingxiu District, Nanning City, Guangxi 530000, China
3 shared publications- Lin Ji
Reproductive Hospital of Guangxi Zhuang Autonomous Region, No. 3, Longyuan Road, Qingxiu District, Nanning City, Guangxi 530000, China
3 shared publications - Xiaocan Lei
Affiliation The First Affiliated Hospital, Gynecology & Obstetrics and Reproductive Medical Center, Clinical Anatomy and Reproductive Medicine Application Institute, School of Basic Medical Sciences, Hengyang Medical School, University of South China, Hengyang, Hunan, China
3 shared publications - Xiaocan Lei
Clinical Anatomy and Reproductive Medicine Application Institute, Hengyang Medical School, University of South China, Hengyang, China
3 shared publications Huimei Wei
Affiliated Hospital of Guilin Medical University, Guilin, Guangxi 541001, China
2 shared publicationsJian Tu
Hunan Province Innovative Training Base for Medical Postgraduates, Hengyang Medical School, University of South China and Yueyang Women & Children's Medical Center, Hengyang and Yueyang, Hunan 421000, China
2 shared publications
Latest Publications
- 16 June 2026
- Published by Springer Nature in Molecular Biology Reports
- Vol. 53 (1)
Targeting programmed cell death in male infertility: pathogenic mechanisms and therapeutic strategies
Male infertility arises from diverse pathological processes, among which dysregulated cell death is a key contributor. Increasing evidence indicates that programmed cell death (PCD) plays a critical role in male infertility and involves multiple regulated forms, including apoptosis, autophagy, pyroptosis, and ferroptosis, as well as the clearance of dying cells through efferocytosis. Unlike necrosis, PCD is an actively regulated process controlled by gene expression and is essential for maintaining testicular homeostasis by eliminating damaged or superfluous cells and modulating cellular defense responses in germ cells, Sertoli cells, and Leydig cells. Aberrant activation or insufficient regulation of these pathways, often driven by oxidative stress, inflammation, or metabolic imbalance, can disrupt spermatogenesis and impair the testicular microenvironment. Therefore, understanding PCD is crucial for clarifying the mechanisms underlying male infertility and for guiding therapeutic development. This review summarizes recent advances in five PCD pathways in male infertility: apoptosis, autophagy, pyroptosis, ferroptosis, and efferocytosis. It focuses on shared molecular nodes, pathway crosstalk, and potential therapeutic targets.
- 16 June 2026
- Published by Springer Nature in Molecular Biology Reports
- Vol. 53 (1)
Targeting programmed cell death in male infertility: pathogenic mechanisms and therapeutic strategies
Male infertility arises from diverse pathological processes, among which dysregulated cell death is a key contributor. Increasing evidence indicates that programmed cell death (PCD) plays a critical role in male infertility and involves multiple regulated forms, including apoptosis, autophagy, pyroptosis, and ferroptosis, as well as the clearance of dying cells through efferocytosis. Unlike necrosis, PCD is an actively regulated process controlled by gene expression and is essential for maintaining testicular homeostasis by eliminating damaged or superfluous cells and modulating cellular defense responses in germ cells, Sertoli cells, and Leydig cells. Aberrant activation or insufficient regulation of these pathways, often driven by oxidative stress, inflammation, or metabolic imbalance, can disrupt spermatogenesis and impair the testicular microenvironment. Therefore, understanding PCD is crucial for clarifying the mechanisms underlying male infertility and for guiding therapeutic development. This review summarizes recent advances in five PCD pathways in male infertility: apoptosis, autophagy, pyroptosis, ferroptosis, and efferocytosis. It focuses on shared molecular nodes, pathway crosstalk, and potential therapeutic targets.
- 31 October 2025
- Published by Elsevier in Phytomedicine
- Vol. 149, 157490
Gut microbiota-metabolite crosstalk mediates icariin’s protection against obesity-induced spermatogenic dysfunction through NF-κB/AMH axis in Sertoli cells
- 31 October 2025
- Published by Elsevier in Phytomedicine
- Vol. 149, 157490
Gut microbiota-metabolite crosstalk mediates icariin’s protection against obesity-induced spermatogenic dysfunction through NF-κB/AMH axis in Sertoli cells
- Open Access
- 15 September 2025
- Published by Baishideng Publishing Group Inc. in World Journal of Diabetes
- Vol. 16 (9) , 107871
Efficacy of inositol supplementation in the prevention and treatment of gestational diabetes mellitus: A meta-analysis
BACKGROUND Gestational diabetes mellitus (GDM) poses a substantial health risk during pregnancy. However, the role of myo-inositol (MI) in GDM prevention and management remains controversial due to conflicting evidence and methodological limitations in previous studies. AIM To assess the efficacy of MI in preventing and treating GDM, providing evidence-based guidance for clinical practice. METHODS A systematic review was conducted on studies published on the PubMed, Web of Science, and Embase databases from their inception date to July 2024. Twelve studies encompassing 9018 patients were included in the meta-analysis using fixed-effect and random-effects models. Heterogeneity was quantified with I 2 statistics and the Cochrane Q test, and study quality was appraised using the A Measurement Tool to Assess Systematic Reviews 2 checklist. RESULTS MI significantly reduced GDM incidence [relative risk (RR): 0.37; 95% confidence interval (CI): 0.32-0.42], fasting blood glucose [standard mean differences (SMD): -1.31 mg/dL; 95%CI: -1.83 to -0.79], and improved glucose tolerance test outcomes at 1-hour (SMD: -2.63 mg/dL; 95%CI: -3.87 to -1.40) and 2-hour (SMD: -0.95 mg/dL; 95%CI: -1.56 to -0.34). It also decreased the risk of preterm birth (RR: 0.37; 95%CI: 0.28-0.47) and pregnancy-induced hypertension (RR: 0.34; 95%CI: 0.25-0.47). A non-significant trend towards reduced cesarean section rates was observed (RR: 0.82; 95%CI: 0.71-0.94). MI reduced birth weight (SMD: -0.25 kg; 95%CI: -0.32 to -0.17), but had no effect on neonatal hypoglycemia (RR: 0.30; 95%CI: 0.08-1.21) or gestational age at birth (SMD: -0.13 weeks; 95%CI: -0.04 to 0.29). CONCLUSION MI demonstrates therapeutic potential in GDM prevention and management, supporting its potential use as a preventive supplement in early pregnancy for high-risk women. Nonetheless, its therapeutic effects in women diagnosed with GDM require further validation.
- 15 September 2025
- Published by Baishideng Publishing Group Inc. in World Journal of Diabetes
- Vol. 16 (9) , 107871
Open AccessEfficacy of inositol supplementation in the prevention and treatment of gestational diabetes mellitus: A meta-analysis
BACKGROUND Gestational diabetes mellitus (GDM) poses a substantial health risk during pregnancy. However, the role of myo-inositol (MI) in GDM prevention and management remains controversial due to conflicting evidence and methodological limitations in previous studies. AIM To assess the efficacy of MI in preventing and treating GDM, providing evidence-based guidance for clinical practice. METHODS A systematic review was conducted on studies published on the PubMed, Web of Science, and Embase databases from their inception date to July 2024. Twelve studies encompassing 9018 patients were included in the meta-analysis using fixed-effect and random-effects models. Heterogeneity was quantified with I 2 statistics and the Cochrane Q test, and study quality was appraised using the A Measurement Tool to Assess Systematic Reviews 2 checklist. RESULTS MI significantly reduced GDM incidence [relative risk (RR): 0.37; 95% confidence interval (CI): 0.32-0.42], fasting blood glucose [standard mean differences (SMD): -1.31 mg/dL; 95%CI: -1.83 to -0.79], and improved glucose tolerance test outcomes at 1-hour (SMD: -2.63 mg/dL; 95%CI: -3.87 to -1.40) and 2-hour (SMD: -0.95 mg/dL; 95%CI: -1.56 to -0.34). It also decreased the risk of preterm birth (RR: 0.37; 95%CI: 0.28-0.47) and pregnancy-induced hypertension (RR: 0.34; 95%CI: 0.25-0.47). A non-significant trend towards reduced cesarean section rates was observed (RR: 0.82; 95%CI: 0.71-0.94). MI reduced birth weight (SMD: -0.25 kg; 95%CI: -0.32 to -0.17), but had no effect on neonatal hypoglycemia (RR: 0.30; 95%CI: 0.08-1.21) or gestational age at birth (SMD: -0.13 weeks; 95%CI: -0.04 to 0.29). CONCLUSION MI demonstrates therapeutic potential in GDM prevention and management, supporting its potential use as a preventive supplement in early pregnancy for high-risk women. Nonetheless, its therapeutic effects in women diagnosed with GDM require further validation.
- 24 February 2025
- Published by Elsevier in International Immunopharmacology
- Vol. 151, 114280
Icariin inhibition of NLRP3 mediated Leydig cell pyroptosis and insulin resistance ameliorates spermatogenesis disorders in obese mice
- 24 February 2025
- Published by Elsevier in International Immunopharmacology
- Vol. 151, 114280
Icariin inhibition of NLRP3 mediated Leydig cell pyroptosis and insulin resistance ameliorates spermatogenesis disorders in obese mice
- Open Access
- 31 October 2024
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 15, 1475531
MMP-9 as a clinical marker for endometriosis: a meta-analysis and bioinformatics analysis
Aim: This study systematically evaluated the potential efficacy of serum matrix metalloproteinase-9 (MMP-9) concentration as a diagnostic marker for endometriosis through meta-analysis. Early and accurate diagnosis of endometriosis, a common gynecological disease, is crucial for improving patient prognosis. Hence, this study aimed to comprehensively analyze the data from multiple studies to assess the diagnostic value of serum MMP-9 concentration for endometriosis.Methods: Articles investigating the association between MMP-9 and endometriosis, published from the inception of the databases until February 2024, were systematically retrieved from multiple databases, including PubMed, Embase, Cochrane, Web of Science, Scopus, and CNKI. Download and analyze the GSE7305, GSE23339, and GSE51981 datasets. Statistical analyses of all eligible studies were conducted using RevMan 5.4, Stata 11.0, and R software version 4.3.3.Results: Fifteen studies fully met the inclusion criteria for the meta-analysis. The concentration of MMP-9 in the blood of patients with endometriosis was significantly higher compared to that of the control group (p < 0.0001). Subgroup analysis based on different stages of endometriosis revealed a trend towards significantly higher serum MMP-9 concentrations in patients, whether in stages I-II or III-IV. Bioinformatics analysis revealed differences in the expression of MMP-9 in endometrial tissue between EMT patients and healthy controls in the GSE7305 and GSE23339 datasets. Additionally, in the GSE51981 dataset, we found significant differences between the normal group and both mild and severe cases of endometriosis.Conclusion: Both the current meta-analysis and bioinformatics analysis indicate differences in MMP-9 concentration levels between endometriosis patients and healthy individuals, with potentially elevated MMP-9 concentrations in serum samples from patients with endometriosis.Systematic review registration: https://www.crd.york.ac.uk/prospero, identifier CRD42024525864.
- 31 October 2024
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 15, 1475531
Open AccessMMP-9 as a clinical marker for endometriosis: a meta-analysis and bioinformatics analysis
Aim: This study systematically evaluated the potential efficacy of serum matrix metalloproteinase-9 (MMP-9) concentration as a diagnostic marker for endometriosis through meta-analysis. Early and accurate diagnosis of endometriosis, a common gynecological disease, is crucial for improving patient prognosis. Hence, this study aimed to comprehensively analyze the data from multiple studies to assess the diagnostic value of serum MMP-9 concentration for endometriosis.Methods: Articles investigating the association between MMP-9 and endometriosis, published from the inception of the databases until February 2024, were systematically retrieved from multiple databases, including PubMed, Embase, Cochrane, Web of Science, Scopus, and CNKI. Download and analyze the GSE7305, GSE23339, and GSE51981 datasets. Statistical analyses of all eligible studies were conducted using RevMan 5.4, Stata 11.0, and R software version 4.3.3.Results: Fifteen studies fully met the inclusion criteria for the meta-analysis. The concentration of MMP-9 in the blood of patients with endometriosis was significantly higher compared to that of the control group (p < 0.0001). Subgroup analysis based on different stages of endometriosis revealed a trend towards significantly higher serum MMP-9 concentrations in patients, whether in stages I-II or III-IV. Bioinformatics analysis revealed differences in the expression of MMP-9 in endometrial tissue between EMT patients and healthy controls in the GSE7305 and GSE23339 datasets. Additionally, in the GSE51981 dataset, we found significant differences between the normal group and both mild and severe cases of endometriosis.Conclusion: Both the current meta-analysis and bioinformatics analysis indicate differences in MMP-9 concentration levels between endometriosis patients and healthy individuals, with potentially elevated MMP-9 concentrations in serum samples from patients with endometriosis.Systematic review registration: https://www.crd.york.ac.uk/prospero, identifier CRD42024525864.
- 28 May 2024
- Published by SAGE Publications in Toxicology and Industrial Health
- Vol. 40 (8) , 465-478
Bibliometrics analysis of hotspots research on infertility syndromes and polystyrene
Polystyrene plastic pollution poses a pressing environmental concern and represents a significant risk factor for infertility. Despite this, a comprehensive overview of the field remains scarce, with future trends largely unknown. Bibliometrics, an applied mathematical and statistical method, offers a means to analyze textual information across various levels, facilitating quantitative assessments of all knowledge carriers and unveiling the nature and developmental trajectories of a discipline. This study aimed to employ bibliometric methods to scrutinize the current status and research hotspots within the realm of polystyrene and infertility. Literature spanning from 1980 to 2023 pertaining to polystyrene and infertility was retrieved from the core database of Web of Science. Quantitative analyses were conducted utilizing CiteSpace (version 5.7.R7), VOSviewer (version 1.6.18.0), and an online literature analysis website ( https://bibliometric.com/ ). The analysis visually represented countries, institutions, authors, journals, and keywords within the field. This study delved into the development history, knowledge structure, research hotspots, and potential trends in the field, furnishing a macro perspective for researchers. The investigation encompassed 267 articles published across 120 journals by 1,352 authors affiliated with 417 institutions in 51 countries, with these articles garnering 10,310 citations across 2,811 journals. The top three countries contributing the most articles were China, the United States, and Germany. In essence, the research hotspots primarily revolved around metabolism, endocrinology, and immunity. Despite China’s relatively recent entry into this field, its rapid development is evident. However, the low citation frequency suggests a need for improved article quality.
- 28 May 2024
- Published by SAGE Publications in Toxicology and Industrial Health
- Vol. 40 (8) , 465-478
Bibliometrics analysis of hotspots research on infertility syndromes and polystyrene
Polystyrene plastic pollution poses a pressing environmental concern and represents a significant risk factor for infertility. Despite this, a comprehensive overview of the field remains scarce, with future trends largely unknown. Bibliometrics, an applied mathematical and statistical method, offers a means to analyze textual information across various levels, facilitating quantitative assessments of all knowledge carriers and unveiling the nature and developmental trajectories of a discipline. This study aimed to employ bibliometric methods to scrutinize the current status and research hotspots within the realm of polystyrene and infertility. Literature spanning from 1980 to 2023 pertaining to polystyrene and infertility was retrieved from the core database of Web of Science. Quantitative analyses were conducted utilizing CiteSpace (version 5.7.R7), VOSviewer (version 1.6.18.0), and an online literature analysis website ( https://bibliometric.com/ ). The analysis visually represented countries, institutions, authors, journals, and keywords within the field. This study delved into the development history, knowledge structure, research hotspots, and potential trends in the field, furnishing a macro perspective for researchers. The investigation encompassed 267 articles published across 120 journals by 1,352 authors affiliated with 417 institutions in 51 countries, with these articles garnering 10,310 citations across 2,811 journals. The top three countries contributing the most articles were China, the United States, and Germany. In essence, the research hotspots primarily revolved around metabolism, endocrinology, and immunity. Despite China’s relatively recent entry into this field, its rapid development is evident. However, the low citation frequency suggests a need for improved article quality.
- Open Access
- 13 March 2023
- Published by Elsevier in Experimental Gerontology
- Vol. 174, 112132
The regulatory feedback of inflammatory signaling and telomere/telomerase complex dysfunction in chronic inflammatory diseases
- 13 March 2023
- Published by Elsevier in Experimental Gerontology
- Vol. 174, 112132
Open AccessThe regulatory feedback of inflammatory signaling and telomere/telomerase complex dysfunction in chronic inflammatory diseases
- Open Access
- 7 October 2022
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 13, 1024320
Posttranslational modifications in pathogenesis of PCOS
Polycystic ovary syndrome (PCOS) is a lifelong reproductive, metabolic, and psychiatric disorder that affects 5-18% of women, which is associated with a significantly increased lifetime risk of concomitant diseases, including type 2 diabetes, psychiatric disorders, and gynecological cancers. Posttranslational modifications (PTMs) play an important role in changes in protein function and are necessary to maintain cellular viability and biological processes, thus their maladjustment can lead to disease. Growing evidence suggests the association between PCOS and posttranslational modifications. This article mainly reviews the research status of phosphorylation, methylation, acetylation, and ubiquitination, as well as their roles and molecular mechanisms in the development of PCOS. In addition, we briefly summarize research and clinical trials of PCOS therapy to advance our understanding of agents that can be used to target phosphorylated, methylated, acetylated, and ubiquitinated PTM types. It provides not only ideas for future research on the mechanism of PCOS but also ideas for PCOS treatments with therapeutic potential.
- 7 October 2022
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 13, 1024320
Open AccessPosttranslational modifications in pathogenesis of PCOS
Polycystic ovary syndrome (PCOS) is a lifelong reproductive, metabolic, and psychiatric disorder that affects 5-18% of women, which is associated with a significantly increased lifetime risk of concomitant diseases, including type 2 diabetes, psychiatric disorders, and gynecological cancers. Posttranslational modifications (PTMs) play an important role in changes in protein function and are necessary to maintain cellular viability and biological processes, thus their maladjustment can lead to disease. Growing evidence suggests the association between PCOS and posttranslational modifications. This article mainly reviews the research status of phosphorylation, methylation, acetylation, and ubiquitination, as well as their roles and molecular mechanisms in the development of PCOS. In addition, we briefly summarize research and clinical trials of PCOS therapy to advance our understanding of agents that can be used to target phosphorylated, methylated, acetylated, and ubiquitinated PTM types. It provides not only ideas for future research on the mechanism of PCOS but also ideas for PCOS treatments with therapeutic potential.
- Open Access
- 16 October 2021
- Published by Springer Nature in Diabetology & Metabolic Syndrome
- Vol. 13 (1) , 1-12
Association of diabetes and obesity with sperm parameters and testosterone levels: a meta-analysis
Background: The present study performed two distinct meta-analyses with common outcomes (sperm parameters); one was performed in obese individuals (and non-obese controls) and the other in diabetic individuals (and non-diabetic controls). Methods: PubMed, Embase, The Cochrane library, Web of Science, Scopus databases were searched to collect clinical studies related to the effects of obesity and diabetes on male sperm from inception to on 1st February 2021. Statistical meta-analyses were performed using the RevMan 5.4 software. Stata16 software was used to detect publication bias. The methodological quality of the included studies was assessed with the Ottawa–Newcastle scale using a star-based system. Results: A total of 44 studies were finally included in the present study, which enrolled 20,367 obese patients and 1386 patients with diabetes. The meta-analysis results showed that both obesity and diabetes were associated with reduced semen volume (obese versus non-obese controls: mean difference (MD) = − 0.25, 95% CI = (− 0.33, − 0.16), p < 0.001; diabetes versus non-diabetic controls: MD = − 0.45, 95% CI = (− 0.63, − 0.27), p < 0.001), reduced sperm count (obese versus non-obese controls: MD = − 23.84, 95% CI = (− 30.36, − 17.33), p < 0.001; diabetes versus non-diabetic controls: MD = − 13.12, 95% CI = (− 18.43, − 7.82), p < 0.001), reduced sperm concentration (obese versus non-obese controls: MD = − 7.26, 95% CI = (− 10.07, − 4.46), p < 0.001; diabetes versus non-diabetic controls: MD = − 11.73, 95% CI = (− 21.44, − 2.01), p = 0.02), reduced progressive motility (obese versus non-obese controls: MD = − 5.68, 95% CI = (− 8.79, − 2.56), p < 0.001; diabetes versus non-diabetic controls: MD = − 14.37, 95% CI = (− 21.79, − 6.96), p = 0.001), and decreased testosterone levels (obese versus non-obese controls: MD = − 1.11, 95% CI = (− 1.92, − 0.30), p = 0.007; diabetes versus non-diabetic controls: MD = − 0.37, 95% CI = (− 0.63, − 0.12), p = 0.004). Conclusions: Current evidence suggests that obesity and diabetes negatively affect sperm parameters in men and are associated with low testosterone levels. Due to the limitation of the number and quality of included studies, the above conclusions need to be verified by more high-quality studies.
- 16 October 2021
- Published by Springer Nature in Diabetology & Metabolic Syndrome
- Vol. 13 (1) , 1-12
Open AccessAssociation of diabetes and obesity with sperm parameters and testosterone levels: a meta-analysis
Background: The present study performed two distinct meta-analyses with common outcomes (sperm parameters); one was performed in obese individuals (and non-obese controls) and the other in diabetic individuals (and non-diabetic controls). Methods: PubMed, Embase, The Cochrane library, Web of Science, Scopus databases were searched to collect clinical studies related to the effects of obesity and diabetes on male sperm from inception to on 1st February 2021. Statistical meta-analyses were performed using the RevMan 5.4 software. Stata16 software was used to detect publication bias. The methodological quality of the included studies was assessed with the Ottawa–Newcastle scale using a star-based system. Results: A total of 44 studies were finally included in the present study, which enrolled 20,367 obese patients and 1386 patients with diabetes. The meta-analysis results showed that both obesity and diabetes were associated with reduced semen volume (obese versus non-obese controls: mean difference (MD) = − 0.25, 95% CI = (− 0.33, − 0.16), p < 0.001; diabetes versus non-diabetic controls: MD = − 0.45, 95% CI = (− 0.63, − 0.27), p < 0.001), reduced sperm count (obese versus non-obese controls: MD = − 23.84, 95% CI = (− 30.36, − 17.33), p < 0.001; diabetes versus non-diabetic controls: MD = − 13.12, 95% CI = (− 18.43, − 7.82), p < 0.001), reduced sperm concentration (obese versus non-obese controls: MD = − 7.26, 95% CI = (− 10.07, − 4.46), p < 0.001; diabetes versus non-diabetic controls: MD = − 11.73, 95% CI = (− 21.44, − 2.01), p = 0.02), reduced progressive motility (obese versus non-obese controls: MD = − 5.68, 95% CI = (− 8.79, − 2.56), p < 0.001; diabetes versus non-diabetic controls: MD = − 14.37, 95% CI = (− 21.79, − 6.96), p = 0.001), and decreased testosterone levels (obese versus non-obese controls: MD = − 1.11, 95% CI = (− 1.92, − 0.30), p = 0.007; diabetes versus non-diabetic controls: MD = − 0.37, 95% CI = (− 0.63, − 0.12), p = 0.004). Conclusions: Current evidence suggests that obesity and diabetes negatively affect sperm parameters in men and are associated with low testosterone levels. Due to the limitation of the number and quality of included studies, the above conclusions need to be verified by more high-quality studies.